Skip to content

Opening book details…

Can I read Thirty-Day Readmission Rate and Healthcare Economic Effects of Patients With Transcatheter Aortic Valve Replacement and Coexisting Chronic Congestive Heart Failure on EtoBox?

Thirty-Day Readmission Rate and Healthcare Economic Effects of Patients With Transcatheter Aortic Valve Replacement and Coexisting Chronic Congestive Heart Failure by Michael Fatuyi; Ndausung Udongwo; Markson Favour; Abbas Alshami; Allen Sanyi; Chidi Amah; Israel Safiriyu; Mohammed Al-Amoodi; Brett Sealove; Mehdi H. Shishehbor; Kamal Shemisa is a Medicine article available to read on EtoBox.

What is Thirty-Day Readmission Rate and Healthcare Economic Effects of Patients With Transcatheter Aortic Valve Replacement and Coexisting Chronic Congestive Heart Failure about?

Transcatheter aortic valve replacement (TAVR) procedures have increased since adoption in 2010. Readmission for TAVR patients with underlying chronic congestive heart failure (cCHF) remains challenging. Therefore, we sought to determine the 30-day readmission rate (30-DRr) of patients who undergo TAVR & co-existing cCHF and its impact on mortality & healthcare utilization in the United States. We performed a retrospective study using the national readmission database year 2017 and 2018. The patients studied were discharged with TAVR as a principal diagnosis and underlying cCHF as a secondary diagnosis according to ICD-10 codes. The primary outcome was a 30-day readmission rate and mortality, while secondary outcomes were the most common diagnoses for readmission, and resource utilization. A total of 76,892 index hospitalization for TAVR with coexisting cCHF: mean age was 79.7 years [SD: ± 2], and 54.5% of patients were males. In-hospital mortality rate for index admission was 1.63%. The 30-DRr was 9.5%. Among the group of readmitted patients, in-hospital mortality rate was 3.13%. Readmission mortality showed a statistically significant increase compared to index mortality (3.13% vs

Who reads Thirty-Day Readmission Rate and Healthcare Economic Effects of Patients With Transcatheter Aortic Valve Replacement and Coexisting Chronic Congestive Heart Failure?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Michael Fatuyi; Ndausung Udongwo; Markson Favour; Abbas Alshami; Allen Sanyi; Chidi Amah; Israel Safiriyu; Mohammed Al-Amoodi; Brett Sealove; Mehdi H. Shishehbor; Kamal Shemisa
Publisher
Elsevier BV
Published
2023
Language
EN
Field
Medicine (Health Sciences)

More by Michael Fatuyi; Ndausung Udongwo; Markson Favour; Abbas Alshami; Allen Sanyi; Chidi Amah; Israel Safiriyu; Mohammed Al-Amoodi; Brett Sealove; Mehdi H. Shishehbor; Kamal Shemisa

Browse all works by Michael Fatuyi; Ndausung Udongwo; Markson Favour; Abbas Alshami; Allen Sanyi; Chidi Amah; Israel Safiriyu; Mohammed Al-Amoodi; Brett Sealove; Mehdi H. Shishehbor; Kamal Shemisa